In stock
CJC-1295 + Ipamorelin
A research blend containing 5 mg Modified GRF (1–29), commonly labelled CJC-1295 without DAC, and 5 mg Ipamorelin per vial. The 10 mg vial size refers to the combined labelled content.
Vial size
£35£3.50 / mg
1
Same-day dispatch on orders paid by 3pm UK time, Monday–Friday
Buy 3+ and save View quantity discounts
Bulk pricing · per vial10 mg
Tiers apply per vial size. For larger or repeat orders,
£5.01 more for free shipping · otherwise £4.99 tracked UK deliveryPlain, secure packaging · tracked UK deliverySold for laboratory research use only. Not for human or veterinary use.
Lot BLD-29-E96 · supplied certificate
CJC-1295 + Ipamorelin specification
- peptide-related purity
- 99.38%
- measured Modified GRF (1-29) / vial
- 5.00 mg
- measured Ipamorelin / vial
- 5.01 mg
- analytical methods
- UHPLC-UV / UHPLC-MS / LC-HRMS
- analysed
- 6–7 Jul 2026
- lot
- BLD-29-E96
- vial size (label claim)
- 10 mg
Storage & handling
Follow the product label and supplied batch instructions. Read our storage and handling guidance for packaging checks and product care, or contact us for missing batch-specific documentation.
Storage & handling guidance →Further reading
Identity, naming and documentation notes from the Research Hub.
CJC-1295 and Ipamorelin blend: composition and certificate →CJC-1295 without DAC and Modified GRF (1–29): identity →Ipamorelin peptide: sequence and certificate identity →How to read a peptide certificate of analysis →